Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/5f/6a/a6/5f6aa654-7d72-399d-3fd8-9e8258530378/mza_8759252498758298122.jpg/600x600bb.jpg
ALPS Podcast on Psychedelic Science
ALPS Podcast
30 episodes
6 days ago
More info on http://www.alpsconference.com ALPS (Awareness Lectures on Psychedelic Science) aims to bring together several outstanding researchers and clinicians working with psychedelic substances. Podcast is both in English and French.
Show more...
Science
RSS
All content for ALPS Podcast on Psychedelic Science is the property of ALPS Podcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
More info on http://www.alpsconference.com ALPS (Awareness Lectures on Psychedelic Science) aims to bring together several outstanding researchers and clinicians working with psychedelic substances. Podcast is both in English and French.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/18987154/18987154-1698597562142-dee72fb00194e.jpg
Rick Doblin - MAPS founder - MDMA-Assisted Therapy for PTSD - Phase 3 Decision by FDA - Alps Conference 2023
ALPS Podcast on Psychedelic Science
25 minutes 34 seconds
2 years ago
Rick Doblin - MAPS founder - MDMA-Assisted Therapy for PTSD - Phase 3 Decision by FDA - Alps Conference 2023

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). He founded MAPS in 1986 and is considered the godfather of the current psychedelic renaissance. 

Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. 

It’s thanks to his MAPS organization that MDMA is currently at phase 3 trial in the US and will be normally approved by the FDA to treat PTSD patients in 2024. 

For more info on Rick Doblin : 

  • MAPS Founder and President

  • Twitter X : @RickDoblin

  • TED Talk : the future of psychedelic-assisted psychotherapy

This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023. 

More info on the Alps Conference 2023 - ⁠Website⁠ - ⁠Twitter⁠ - ⁠Facebook⁠ - ⁠Instagram⁠ - ⁠Youtube

ALPS Podcast on Psychedelic Science
More info on http://www.alpsconference.com ALPS (Awareness Lectures on Psychedelic Science) aims to bring together several outstanding researchers and clinicians working with psychedelic substances. Podcast is both in English and French.